PT  - JOURNAL ARTICLE
AU  - Henry Loeffler-Wirth
AU  - Maria Schmidt
AU  - Hans Binder
TI  - Covid-19 trajectories – Monitoring pandemic in the worldwide context
AID  - 10.1101/2020.06.04.20120725
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.04.20120725
4099  - http://medrxiv.org/content/early/2020/06/05/2020.06.04.20120725.short
4100  - http://medrxiv.org/content/early/2020/06/05/2020.06.04.20120725.full
AB  - Background Covid-19 pandemic is developing worldwide with common dynamics but also with partly marked differences between regions and countries. They are not completely understood, but presumably, provide one clue to find ways to mitigate epidemics until exit strategies to its eradication become available.Method We provide a monitoring tool available at www.izbi.de. It enables inspection of the dynamic state of the epidemic in 187 countries using trajectories. They visualize transmission and removal rates of the epidemic and this way bridge epi-curve tracking with modelling approaches.Results Examples were provided which characterize state of epidemic in different regions of the world in terms of fast and slow growing and decaying regimes and estimate associated rate factors. Basic spread of the disease associates with transmission between two individuals every two-three days on the average. Non-pharmaceutical interventions decrease this value to up to ten days where ‘complete lock down’ measures are required to stop the epidemic. Comparison of trajectories revealed marked differences between the countries regarding efficiency of measures taken against the epidemic. Trajectories also reveal marked country-specific dynamics of recovery and death rates.Conclusions The results presented refer to the pandemic state in May 2020 and can serve as ‘working instruction’ for timely monitoring using the interactive monitoring tool as a sort of ‘seismometer’ for the evaluation of the state of epidemic, e.g., the possible effect of measures taken in both, lock-down and lock-up directions. Comparison of trajectories between countries and regions will support developing hypotheses and models to better understand regional differences of dynamics of Covid-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding used.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Our study used exclusively publicly available data and does not require ethical oversight.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData were provided by https://systems.jhu.edu/research/public-health/ncov/ and https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Fallzahlen.html The tool is available via the websites of IZBI (www.izbi.de) and the Leipzig Health Atlas (https://www.health-atlas.de/models/28). https://www.health-atlas.de/models/28